tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Bristol Myers initiated with an Overweight at Barclays
The FlyBristol Myers initiated with an Overweight at Barclays
2h ago
BMY
FDA to begin requiring on clinical trial
PremiumThe Fly
FDA to begin requiring on clinical trial
1d ago
AZN
BMY
FDA to begin requiring one clinical trial in drug approvals
PremiumThe Fly
FDA to begin requiring one clinical trial in drug approvals
1d ago
AZN
BMY
Balanced Risk-Reward Keeps Bristol-Myers Squibb Rated Hold as CELMoD Franchise Awaits Key Iberdomide Data
PremiumRatings
Balanced Risk-Reward Keeps Bristol-Myers Squibb Rated Hold as CELMoD Franchise Awaits Key Iberdomide Data
2d ago
BMY
Bristol Myers says FDA accepts NDA for iberdomide
PremiumThe Fly
Bristol Myers says FDA accepts NDA for iberdomide
2d ago
BMY
Bristol Myers’ treatment of follicular lymphoma granted FDA orphan designation
PremiumThe FlyBristol Myers’ treatment of follicular lymphoma granted FDA orphan designation
6d ago
BMY
BMY-Backed Milvexian Stroke Trial Moves Forward, Keeping Upside Optionality Alive
Premium
Company Announcements
BMY-Backed Milvexian Stroke Trial Moves Forward, Keeping Upside Optionality Alive
6d ago
BMY
Bristol-Myers Squibb Expands Real-World MDS Footprint in Asia With New Registry Study
Premium
Company Announcements
Bristol-Myers Squibb Expands Real-World MDS Footprint in Asia With New Registry Study
6d ago
BMY
Bristol-Myers Squibb: Solid Near-Term Execution and 2026 EPS Boost from Eliquis, but Limited Long-Term Visibility Supports Hold Rating
PremiumRatings
Bristol-Myers Squibb: Solid Near-Term Execution and 2026 EPS Boost from Eliquis, but Limited Long-Term Visibility Supports Hold Rating
9d ago
BMY
Bristol Myers price target raised to $40 from $37 at Morgan Stanley
PremiumThe Fly
Bristol Myers price target raised to $40 from $37 at Morgan Stanley
13d ago
BMY
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
PremiumThe Fly
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
13d ago
BA
AZN
Bristol Myers price target raised to $68 from $64 at BofA
PremiumThe Fly
Bristol Myers price target raised to $68 from $64 at BofA
13d ago
BMY
Bristol Myers price target raised to $72 from $62 at Guggenheim
PremiumThe FlyBristol Myers price target raised to $72 from $62 at Guggenheim
13d ago
BMY
Bristol Myers price target raised to $64 from $60 at Citi
Premium
The Fly
Bristol Myers price target raised to $64 from $60 at Citi
13d ago
BMY
Bristol Myers price target raised to $60 from $55 at Wells Fargo
Premium
The Fly
Bristol Myers price target raised to $60 from $55 at Wells Fargo
13d ago
BMY
Reiterating Buy on Bristol-Myers Squibb: Near-Term Outperformance and Pipeline-Driven Upside Support Higher $68 Target
PremiumRatings
Reiterating Buy on Bristol-Myers Squibb: Near-Term Outperformance and Pipeline-Driven Upside Support Higher $68 Target
14d ago
BMY
Bristol-Myers Squibb Bets On New Growth Engines
PremiumCompany Announcements
Bristol-Myers Squibb Bets On New Growth Engines
14d ago
BMY
Reiterating Buy on Bristol-Myers Squibb: Milvexian’s Validated FXIa Mechanism and Underappreciated Stroke Prevention Upside Support $65 Target
PremiumRatings
Reiterating Buy on Bristol-Myers Squibb: Milvexian’s Validated FXIa Mechanism and Underappreciated Stroke Prevention Upside Support $65 Target
14d ago
BMY
Truist incrementally positive on Bristol Myers after Bayer asundexian data
PremiumThe Fly
Truist incrementally positive on Bristol Myers after Bayer asundexian data
14d ago
BMY
TrumpRx website using technology from GoodRx, STAT says
PremiumThe FlyTrumpRx website using technology from GoodRx, STAT says
14d ago
AZN
BMY
Morning Movers: Ralph Lauren and Qualcomm sink after earnings
Premium
The Fly
Morning Movers: Ralph Lauren and Qualcomm sink after earnings
14d ago
EL
RL
Bristol Myers Squibb Posts 2025 Results, Raises Dividend
Premium
Company Announcements
Bristol Myers Squibb Posts 2025 Results, Raises Dividend
14d ago
8K
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >